Back to Peptide Encyclopedia
Growth Hormone SecretionModerate Evidence
CJC-1295
GHRH analog in two forms: with DAC (extended half-life) and without DAC (pulsatile release).
Compoundable4 protocols
Research-only — no FDA/EMA approval
·Educational information. Not medical advice or a recommendation for use.Key Facts: CJC-1295
Category
Growth Hormone Secretion
Evidence
Moderate Evidence
Availability
Compoundable
Protocols
4
Research Overview & Mechanisms
Stimulates the pituitary gland to release growth hormone.
Reported Research Benefits
GH secretion
Muscle support
Recovery
Available Protocols
Frequently Asked Questions
FAQ
GHRH analog in two forms: with DAC (extended half-life) and without DAC (pulsatile release).
Advanced Compound Intelligence
—
Human studies
—
Key studies
1
Interactions
Moderate Evidence
Evidence tier
Verified intelligence
Research summaryClinical Evidence
Moderate Evidence
View all studies on PubMedPhase II clinical trials or limited Phase III data available.
Known Interactions
Synergistic
Compare CJC-1295
Scientific Sources & Further Reading
Explore peer-reviewed research about CJC-1295:
External links open in new tabs. Always verify information with qualified healthcare providers.
Important Disclaimer
The content of this website is provided exclusively for informational and educational purposes within the context of research literature.
Read the full Disclaimer →